MB07803
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MB07803, covering 2011-10-03 to 2011-10-03. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy Study of MB07803 Administered to Patients With Type 2 Diabetes Mellitus [Phase 2]